KYN-175

N/A

Report date: 2024/01/24 15:36:06
NME

Base Information

Drug NameKYN-175
Drug Alias NameKYN-175IK-175
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAryl hydrocarbon receptor antagonists
TargetsAryl hydrocarbon receptor
Therapy Area/IndicationsSolid tumoursUrinary Bladder DiseasesNeoplasm Metastasis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIkena Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyIkena Oncology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder DiseasesNeoplasm Metastasis +[6] 
Inactive IndicationsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A